About SK
SK is a company based in Seoul (South Korea) founded in 1953. The company has 1 employees as of April 09, 2024. SK has completed 8 acquisitions, including AMPAC Fine Chemicals, Eureka Midstream and Imexpharm. SK offers products and services including Chemical Products and Social Value Programs.
- Headquarter Seoul, South Korea
- Employees 1 as on 09 Apr, 2024
- Stage Public
-
Sectors
Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sk E&C India Private Limited
- Date of Incorporation 09 Nov, 2006
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$14.38 M (USD)-2.09as on Mar 31, 2016
-
Net Profit
$114.09 K (USD)-94.55as on Mar 31, 2016
-
EBITDA
$846.03 K (USD)-66.04as on Mar 31, 2016
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 09, 2024
-
Investments & Acquisitions
AMPAC Fine Chemicals
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SK
SK is a publicly listed company on the TSE with ticker symbol 9446 in Japan, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SK
SK offers a comprehensive portfolio of products and services, including Chemical Products and Social Value Programs.
Chemical products are manufactured and supplied for uses such as packaging and expos
Social value programs are offered through foundations and initiatives that promote enterprise and community engagement
People of SK
Unlock access to complete
Funding Insights of SK
Detailed funding history for SK
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SK
SK has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include AMPAC Fine Chemicals, Eureka Midstream and Imexpharm.
Investment portfolio details for SK
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Targeted protein degrader therapies are developed for cancer and hematology.
|
Locked | Locked | 2021 | Locked | |
|
SiC power semiconductor products are manufactured alongside foundry services.
|
Locked | Locked | 2017 | Locked | |
|
Gene and cell therapy products, including lentiviral vectors, are manufactured.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for SK
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SK
Detailed financials for SK
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sk Comparisons
Peer comparison for SK
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SK
Detailed competitors of SK
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sk
Complete news archive for SK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SK
SK was founded in 1953.
SK is headquartered in Seoul, South Korea.
Chey Tae-won is the current CEO of SK.
As of Apr 09, 2024, the latest employee count at SK is 1.
Annual revenue of SK is $14.38M as on Mar 31, 2016.
SK was established in 1953 in Seoul, South Korea, as a private equity firm. Focus is placed on sectors including energy, chemicals, semiconductors, logistics, and additional industries. Operations involve investment activities across these areas. In 2022, annual revenues of 104.64 billion were recorded, alongside a net profit of 0.85 billion. Leadership is provided by Chairman Chey Tae-won.
SK offers Chemical Products and Social Value Programs.
Yes, SK is publicly traded on TSE under the ticker symbol 9446.
SK has made 8 acquisitions, including AMPAC Fine Chemicals, Eureka Midstream, and Imexpharm.
The ticker symbol of SK is 9446 on TSE.